A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
Titel:
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
Auteur:
Hainsworth, John D. Reeves, James A. Mace, Joseph R. Crane, Edward J. Hamid, Oday Stille, John R. Flynt, Amy Roberson, Stephanie Polzer, John Arrowsmith, Edward R.